ArticleJournal of cellular and molecular medicine2021

CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis.

Libo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.